Apollo Hospitals to hive off retail pharmacy business into new company
Apollo Pharmacy (APL) will be a wholly owned subsidiary of Apollo Medicals. The listed parent company, Apollo Hospitals Enterprise will hold 25.5% stake in Apollo Medicals (AMPL) . (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 14, 2018 Category: Pharmaceuticals Source Type: news

Cipla's subsidiary to acquire US-based Avenue Therapeutics for $ 215 million
At the second stage, InvaGen or its affiliates will acquire the remaining shares of Avenue's common stock, for up to USD 180 million in the aggregate. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Suven Life gets product patents from Australia, Hong Kong
These patents are valid till 2036 and 2033 respectively, the company said in a BSE filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for Asthma drug
Quoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma inks pact to acquire Australian pharma firm's product
Based out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mn
The acquisition is for a cash consideration of USD 12.5 million, it added. The indicative time period for completion of the acquisition is January 2019, Aurobindo Pharma said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2018 Category: Pharmaceuticals Source Type: news

Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients
The approved products is a generic therapeutic equivalent version of Roche's Valcyte. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for anti-fungal ointment
The group has more than 226 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2018 Category: Pharmaceuticals Source Type: news

We ’re just aggregators, e-pharmacies tell Madras High Court
This comes after the Madras High Court, in a recent injunction, restrained unlicenced e-pharmacies from doing business. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 5, 2018 Category: Pharmaceuticals Source Type: news

Clinical trials on Ayurvedic medicine against dengue underway: Shripad Naik
Rajesh Kotecha, secretary of AYUSH ministry, said the medicine is expected to be ready after multilevel trials in the next couple of years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo recalls hypertensive drug in US citing cancer risk
ScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Lupin recalls 6,752 bottles of Testosterone topical solution from US
The product is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 4, 2018 Category: Pharmaceuticals Source Type: news

Indian pharma companies maintaining good compliance standards: Frances Zipp, CEO, Lachman Consultants
One of the unique opportunities for the industry to come out on scientific and safe manner is to engage closely on the latest developments in the industry, feels Frances Zipp, CEO at Lachman Consultants. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2018 Category: Pharmaceuticals Source Type: news

Sajjala Bio to begin clinical trials on diabetes drug
In a statement, the Hyderabad-based company that reported Rs 15 crore of revenue last fiscal year, said it would soon take up clinical studies on the drug. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2018 Category: Pharmaceuticals Source Type: news

Implementation date for track and trace system for exports of drug formulations extended
The decision is applicable for both non-SSI (small scale industry) and SSI-manufactured drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 2, 2018 Category: Pharmaceuticals Source Type: news

NPPA fixes retail price of 68 drug formulations
Further, the authority has also fixed ceiling prices of three scheduled formulations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 2, 2018 Category: Pharmaceuticals Source Type: news

E-pharmacies seek more clarity from Madras High Court on sales stay
The Tamil Nadu Chemists and Druggists Association had earlier filed a writ petition in the Madras High Court to block websites from India which sell Schedule H, H1and Schedule X medicines. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 2, 2018 Category: Pharmaceuticals Source Type: news

Delhi High Court to hear Daiichi's case to block Fortis deal on November 15
The court will continue hearing arguments in this matter on November 15. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 1, 2018 Category: Pharmaceuticals Source Type: news

Weak rupee likely to help pharma companies post double-digit growth
The rupee has been on a free fall against the US dollar, making the currency depreciation a political issue. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 1, 2018 Category: Pharmaceuticals Source Type: news

Strides Pharma Science to get USD 20 mn funding for consumer healthcare business
Drug firm Strides Pharma Science Wednesday said it has partnered with funds advised by ICP-III Investment Advisors, which will infuse USD 20 million into its consumer healthcare business. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 31, 2018 Category: Pharmaceuticals Source Type: news

Madras High Court grants interim injunction against online medicine sale
The druggists association had contended that e-tailers dealing in medicines are operating without proper licences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 31, 2018 Category: Pharmaceuticals Source Type: news

No evidence of polio type- 2 virus strain: Bio-med
However last week the Ghaziabad district court granted bail to Mr Garg on the grounds that the arrests made under the FIR by drug inspectors were unlawful. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 31, 2018 Category: Pharmaceuticals Source Type: news

Desi pharma companies top in biosimilars globally
​​Biosimilars are approved versions of biopharmaceuticals — complex medicines manufactured using live organisms, as against conventional drugs that are based on chemical composition. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 29, 2018 Category: Pharmaceuticals Source Type: news

Cipla gets USFDA nod for hypertension, cardiac drug
Cipla said, Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure, Angina Pectoris (chest pain or discomfort due to coronary heart disease). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 29, 2018 Category: Pharmaceuticals Source Type: news

Granules' US unit gets two USFDA observations
As per the USFDA, a Form 483, is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions that in its judgment may constitute violations of FD&C Act. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 29, 2018 Category: Pharmaceuticals Source Type: news

Local pharma formulators to benefit from new USFDA generic guidance: Report
This will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend report by India Ratings. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 28, 2018 Category: Pharmaceuticals Source Type: news

‘Banned ingredients in diet pills putting Indians at risk’
Several dietary supplements, most of which are widely available in India, have been found adulterated with unapproved and even banned pharmaceutical ingredients in the US, a latest study published in ‘JAMA Open’ revealed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 27, 2018 Category: Pharmaceuticals Source Type: news

DowDuPont withdrew GM Corn trials as requisite states didn't give permission
Subbarao KV, MD (South Asia), Corteva Agriscience, the agriculture division of DowDuPont, also said that once the Genetic Engineering Appraisal Committee (GEAC) allows commercial cultivation of GM food crop, the company would hold final field trials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 26, 2018 Category: Pharmaceuticals Source Type: news

High drug prices due to unreasonable margins of companies: CCI
​​The CCI also prescribed various ways to reduce the anti-trade practices in the policy paper. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 24, 2018 Category: Pharmaceuticals Source Type: news

Polio vaccine contamination case: Bio-Med MD gets bail, drug inspectors apologise to court
Bio-Med, a 43-year old Ghaziabad-based vaccine maker came under the scanner of the Drug regulator last month when the inspectors claimed they found polio type 2 virus in the vaccines made by Bio-Med. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 24, 2018 Category: Pharmaceuticals Source Type: news

Daiichi alleges fraudulent siphoning of over Rs 2,000 crore by Singh brothers
Daiichi has alleged that the Singhs gave 25 entities linked to them loans that far exceeded the worth of these companies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2018 Category: Pharmaceuticals Source Type: news

Johnson and Johnson asked to cut down price of new TB drug
​​ To ensure the drug is accessible to all, MSF called on J&J to issue a non-exclusive license to the Medicines Patent Pool to allow for price-lowering competition among generic producers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on Wednesday
ET on October 11 had reported that Zydus Cadila is the frontrunner for the Kraft Heinz India portfolio. Zydus Cadila is the country ’s fourth-largest Indian pharmaceutical company with Rs 11,600 crore in FY18 sales. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2018 Category: Pharmaceuticals Source Type: news

PIL filed in Bombay High Court seeking curbs on antibiotics sale without prescription
The petition followed investigation by an activist who found that antibiotics under ‘restricted use’ were freely available over the counter across pharmacies in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 23, 2018 Category: Pharmaceuticals Source Type: news

Are companies bribing doctors to push vaccine combos?
Paediatricians question these huge price increases with the addition of just one more vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 22, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for generic gout attacks drug
The company has received the tentative approval from the USFDA to market Colchicine tablets USP in the strength of 0.6 mg, Zydus Cadila said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 18, 2018 Category: Pharmaceuticals Source Type: news

Ajay Piramal eyes $1 billion in contract pharma sale
Deliberations are at an early stage, and Piramal Enterprises could still decide against pursuing a deal, the people said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 16, 2018 Category: Pharmaceuticals Source Type: news

DCGI asks company to recall Ozurdex Intravitreal implants
During a routine manufacturing inspection, a silicone particle, approximately 300 microns in diameter, was observed in dispensed Ozurdex implants, a statement by the Allergan India Private Limited said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 16, 2018 Category: Pharmaceuticals Source Type: news

Big pharma companies plan cheaper alternatives for Ayushman Bharat
Integration of the existing Pradhan Mantri Jan Aushadhi Pariyojana (PMBJP), which supplies generic medicines at around 50% discount will strengthen Ayushman Bharat. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 16, 2018 Category: Pharmaceuticals Source Type: news

Dr Reddy ’s to sell Hyderabad API unit to Therapiva
Therapiva is a joint venture between Omnicare Drugs India, a wholly-owned subsidiary of Abu Dhabi based Neopharma LLC, and Laxai Life Sciences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 15, 2018 Category: Pharmaceuticals Source Type: news

Exploring ways to establish presence in China as part of APAC region push: Lupin
The Mumbai-based firm expects to generate revenues of over USD 100 million from the region, excluding the Japanese market, over the next few years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 14, 2018 Category: Pharmaceuticals Source Type: news

Sun pharma invests 120 crore in Assam to set up production line
According to statement from Assam government the company has already invested Rs 700 crore in this manufacturing facility in the state and another Rs 200 crore is going to be invested. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2018 Category: Pharmaceuticals Source Type: news

Drug makers may have to pay 5 times more for pharma imports
The ministry is once again mulling a hike in fees for several regulatory submissions for foreign drug makers, said two senior health ministry officials. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2018 Category: Pharmaceuticals Source Type: news

Shivinder Singh offers to pay own share of Daiichi Sankyo's Rs 3,500-cr award
The High Court has asked Singh brothers to come up with a "viable" plan by October 30. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2018 Category: Pharmaceuticals Source Type: news

UP to open 6 pharma parks; gets Rs 5,000-6,000 cr commitment
The UP government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma companies. ​ (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2018 Category: Pharmaceuticals Source Type: news

Shivinder Singh offers to mediate with Daiichi Sankyo over Rs 3,500 crore arbitration award
The Delhi High Court has asked him to come up with a "viable" plan by the next date of hearing on October 30. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2018 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for infections treatment drug
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin Oral suspension 100 mg /5 mL and 200 mg/5 mL. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2018 Category: Pharmaceuticals Source Type: news

Delhi HC seeks Centre's reply on plea to take action against online pharmacies
The petition came up for hearing before Justice Vibhu Bakhru which listed it for further proceedings on February 25 next year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2018 Category: Pharmaceuticals Source Type: news

Bank fraud: ED attaches Rs 5.4-cr assets in Gujarat pharma firm case
The attached immovable properties, one each in Faridabad and Gurgaon, belong to Delhi-based businessman Gagan Dhawan, who was arrested by the ED and is out on bail. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 6, 2018 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for breast cancer drug
The company said it will manufacture the drug at the group's formulations manufacturing facility at SEZ, Ahmedabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 5, 2018 Category: Pharmaceuticals Source Type: news